Artivion Inc. (CYL)

Overview

Artivion, Inc., initially known as CryoLife, Inc., before its name change in January 2022, is a prominent entity in the medical devices and implantable human tissues sector, with operations extending globally. Founded in 1984 and based in Kennesaw, Georgia, the company is adept at manufacturing, processing, and distributing a wide array of medical devices. These products are designed for use in various medical procedures, including cardiac, vascular, neurologic, and pulmonary operations. Artivion, Inc. caters to a diverse clientele, including physicians, hospitals, and other healthcare facilities, with its offerings significantly influencing the practices of cardiac, vascular, thoracic, and general surgeons across the world.

Products and Services

• BioGlue: A unique polymer made from bovine blood protein, used across a range of surgical procedures for protein cross-linking.
• Cardiac Preservation Services: Specialized services aimed at maintaining cardiac health during surgery.
• PhotoFix: A bovine pericardial patch favored for its durability and versatility in surgical applications.
• Aortic Arch Stent Grafts (E-vita Open Plus and E-vita Open Neo): Advanced solutions for complicated aortic surgeries, offering custom-designed options to meet specific patient needs.
• E-xtra Design Engineering Systems: Tailored engineering solutions for tackling aortic vascular diseases effectively.
• E-nside: An off-the-shelf stent graft designed for the thoraco-abdominal disease treatment, simplifying complex procedures.
• E-vita THORACIC 3G: A cutting-edge endovascular solution for thoracic aortic aneurysm treatments, highlighting technological advancements in this field.
• E-ventus BX: A balloon-expandable peripheral stent graft designed for the precise treatment of renal and pelvic arteries.
• E-liac and E-tegra: Stent graft systems focused on treating aneurysmal conditions in iliac arteries and infrarenal abdominal aortic aneurysms, respectively, enhancing the range of vascular interventions available.
• Synthetic Vascular Grafts: Synthetically engineered grafts for open aortic and peripheral vascular surgical procedures, exemplifying the advancements in synthetic biocompatible materials.
• PerClot: An absorbable powdered hemostat used in various surgical interventions to promote hemostasis efficiently.
• Cardiac Laser Therapy Products: Innovative solutions for angina treatment, using laser technology to provide relief and improve patient outcomes.
• CryoVein and CryoArtery: Vascular preservation services for femoral veins and arteries, enhancing the longevity and success rates of vascular surgeries.
• On-X Prosthetic Heart Valves (Aortic and Mitral) and Ascending Aortic Prosthesis: State-of-the-art artificial heart valves and associated prostheses for cardiac surgery, representing significant achievements in materials science and biomechanics.
• CarbonAid CO2 Diffusion Catheters and Chord-X ePTFE Sutures: Advanced catheter systems for CO2 management and high-quality sutures for mitral chordal replacement, illustrating the precision manufacturing techniques used in medical devices.
• Ascyrus Medical Dissection Stents: Specialized stents designed for the treatment of arterial dissections, contributing to safer cardiovascular procedures.
• Pyrolytic Carbon Coating Services: Specialized services offered to other medical device manufacturers, highlighting Artivion, Inc.’s capacity for innovation and support within the medical device manufacturing industry.